Showing results (1571-1580 of 3,085) with videos related to
Sort By:
Pageof 309
Drug Safety|September 12, 2002
Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in JapanKazuo Samizo, Eri Kawabe, Shiro Hinotsu, et al.Drug Safety|September 12, 2002
Incidence of herb-induced aconitine poisoning in Hong Kong: impact of publicity measures to promote awareness among the herbalists and the publicThomas Y K ChanDrug Safety|September 21, 2002
A benefit-risk assessment of extended-release oxybutyninMartin C MichelDrug Safety|September 21, 2002
Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathyHelmut Sinzinger, Fahdi Chehne, Graziana LupattelliDrug Safety|June 23, 2001
Evaluation of drug-induced QT interval prolongation: implications for drug approval and labellingM Malik, A J CammDrug Safety|August 28, 2001
Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?W K Kraft, S A WaldmanDrug Safety|October 26, 2001
Oral contraceptives and cancer: an updateC La Vecchia, A Altieri, S Franceschi, et al.Drug Safety|March 16, 2021
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical TrialsJuliana Hey-Hadavi, Daniel Seekins, Melissa Palmer, et al.Drug Safety|January 19, 2022
β-Blockers and the Risk of Depression: A Matched Case-Control StudyDelia Bornand, Daphne Reinau, Susan S Jick, et al.Drug Safety|May 1, 1990
Monoamine oxidase inhibitor update. Potential adverse food and drug interactionsS B Lippman, K NashPageof 309